Product Description: Bellericagenin A is a pentacyclic triterpenic acid isolated from the bark of Terminalia bellerica. Bellericagenin A exhibits antimicrobial activity. Bellericagenin A exhibits a high affinity to alcohol dehydrogenase (ADH), which has the potential for ameliorating the alcoholic liver injury[1][2].
Applications: COVID-19-immunoregulation
Formula: C30H48O6
References: [1]Mahato S B, et al., Pentacyclic triterpenoid sapogenols and their glycosides from Terminalia bellerica[J]. Tetrahedron, 1992, 48(12): 2483-2494./[2]Banjan B, et al., Computational identification of potential bioactive compounds from Triphala against alcoholic liver injury by targeting alcohol dehydrogenase. Mol Divers. 2024 May 14.
CAS Number: 141630-18-4
Molecular Weight: 504.70
Research Area: Infection
Target: Bacterial